Vascular access device insertion can be difficult and painful. And after insertion, 25% to 50% fail due to infection, blockage, dislodgement or vessel damage. Our goal is to make vascular access complications history. The AVATAR Group undertakes committed scientific work to improve hospital and hom...See more
Headquarter Australia |
Year founded 2007 (17 years) |
Funding status Private |
Company type SME |
Founder
Chapter Lead
Director Of Education